We came together around a shared belief: better care begins with better evidence, and that modern diagnostics should unite reproducible biological measurement with advanced computation.
Oxford Cancer Analytics brings together a multidisciplinary team united by scientific rigour and a shared commitment to clinical impact. Our platform generates evidence-based insights designed to support clinical decision-making in lung disease, starting with Chronic Obstructive Pulmonary Disease (COPD), with broader applicability including lung cancer.



